-
The current economy should be enough to convince clinical research (CR) sites that they need better strategies to handle the rollercoaster ride of the research business cycle if they want to survive and thrive for the long term.
-
Assessing a protocol's feasibility should be a top priority for clinical trial sites. And it's a good strategy to have a thorough feasibility process in place.
-
Clinical trials directors should take reasonable steps to manage their organization's risk in human subjects research. It's not wise to assume that someone else is taking care of this issue, an expert advises.
-
It's good timing to improve your research compliance program now that billions more dollars in federal funding from the health care reform and stimulus package continue to be pumped into the research economy. Such money brings increased regulatory scrutiny, and this means clinical trial (CT) sites will need to make certain they are following all rules.
-
Cancer Care Northwest of Spokane, WI, is proof that a clinical research site doesn't need to be large to have a successful billing compliance program.
-
It's the rare clinical trial site that stays consistently busy with research. Most sites need to do at least a little marketing. Only they might not call it that, or even have a business strategy for recruiting and maintaining a steady business stream.
-
-
-
Superficial venous thrombosis is not a benign condition and deserves close attention.
-
Lenient rate control was not inferior to strict rate control in patients with AF in terms of major clinical events.
